Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balu Krishna Sasidharan

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Advances in Radiation Oncology|June 13, 2020
Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and OutcomesZhenwei Zou, Stephen R Bowen, Hannah M T Thomas, et al.
Journal of Cancer Research and Therapeutics|January 4, 2020
A phase 2 randomized controlled trial of oral resistant starch supplements in the prevention of acute radiation proctitis in patients treated for cervical cancerBalu Krishna Sasidharan, Balamurugan Ramadass, P N Viswanathan, et al.
International Journal of Particle Therapy|November 28, 2019
Clinical Monte Carlo versus Pencil Beam Treatment Planning in Nasopharyngeal Patients Receiving IMPTBalu Krishna Sasidharan, Saif Aljabab, Jatinder Saini, et al.
Journal of Gastrointestinal Cancer|March 29, 2022
Utility of Mid-treatment DWI in Selecting Pathological Responders to Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal CancerNeenu Oliver John, Aparna Irodi, Hannah Mary T Thomas, et al.
Diagnostics (Basel, Switzerland)|March 14, 2026
Decoding Uncertainty Quantification for Oncology-An Illustration Using RadiomicsFlorian van Daalen, Balu Krishna Sasidharan, C Praveenraj, et al.
Journal of Gastrointestinal Cancer|July 29, 2020
Patterns of Recurrence in Locally Advanced Resectable Oesophageal Carcinoma: Retrospective Review from a Tertiary Cancer Centre in South IndiaAnindita Das, Suraj Surendran, Manu Mathew, et al.
The British Journal of Radiology|August 1, 2019
Comparison of regional lung perfusion response on longitudinal MAA SPECT/CT in lung cancer patients treated with and without functional tissue-avoidance radiation therapyHannah Mary T Thomas, Jing Zeng, Howard J Lee, et al.
Journal of Minimal Access Surgery|September 20, 2022
Feasibility, safety and oncological outcomes of minimally invasive oesophagectomy following neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma - Experience from a tertiary care centreSuraj Surendran, Geet Midha, Negine Paul, et al.
South Asian Journal of Cancer|December 22, 2025
Feasibility, Safety, and Factors Predicting Completion of CROSS Protocol-Based Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma: Experience from an Indian Tertiary Care Cancer CenterSuraj Surendran, Geet Midha, Manu Mathew, et al.
Acta Neurochirurgica|February 20, 2024
Is radiomics a useful addition to magnetic resonance imaging in the preoperative classification of PitNETs?Sathya A, Abhijit Goyal-Honavar, Ari G Chacko, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Advances in Radiation Oncology|June 13, 2020
Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and OutcomesZhenwei Zou, Stephen R Bowen, Hannah M T Thomas, et al.
Journal of Cancer Research and Therapeutics|January 4, 2020
A phase 2 randomized controlled trial of oral resistant starch supplements in the prevention of acute radiation proctitis in patients treated for cervical cancerBalu Krishna Sasidharan, Balamurugan Ramadass, P N Viswanathan, et al.
International Journal of Particle Therapy|November 28, 2019
Clinical Monte Carlo versus Pencil Beam Treatment Planning in Nasopharyngeal Patients Receiving IMPTBalu Krishna Sasidharan, Saif Aljabab, Jatinder Saini, et al.
Journal of Gastrointestinal Cancer|March 29, 2022
Utility of Mid-treatment DWI in Selecting Pathological Responders to Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal CancerNeenu Oliver John, Aparna Irodi, Hannah Mary T Thomas, et al.
Diagnostics (Basel, Switzerland)|March 14, 2026
Decoding Uncertainty Quantification for Oncology-An Illustration Using RadiomicsFlorian van Daalen, Balu Krishna Sasidharan, C Praveenraj, et al.
Journal of Gastrointestinal Cancer|July 29, 2020
Patterns of Recurrence in Locally Advanced Resectable Oesophageal Carcinoma: Retrospective Review from a Tertiary Cancer Centre in South IndiaAnindita Das, Suraj Surendran, Manu Mathew, et al.
The British Journal of Radiology|August 1, 2019
Comparison of regional lung perfusion response on longitudinal MAA SPECT/CT in lung cancer patients treated with and without functional tissue-avoidance radiation therapyHannah Mary T Thomas, Jing Zeng, Howard J Lee, et al.
Journal of Minimal Access Surgery|September 20, 2022
Feasibility, safety and oncological outcomes of minimally invasive oesophagectomy following neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma - Experience from a tertiary care centreSuraj Surendran, Geet Midha, Negine Paul, et al.
South Asian Journal of Cancer|December 22, 2025
Feasibility, Safety, and Factors Predicting Completion of CROSS Protocol-Based Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma: Experience from an Indian Tertiary Care Cancer CenterSuraj Surendran, Geet Midha, Manu Mathew, et al.
Acta Neurochirurgica|February 20, 2024
Is radiomics a useful addition to magnetic resonance imaging in the preoperative classification of PitNETs?Sathya A, Abhijit Goyal-Honavar, Ari G Chacko, et al.
Pageof 2